Azasite

Azasite is a brand name of azithromycin ophthalmic, approved by the FDA in the following formulation(s):

AZASITE (azithromycin - solution/drops; ophthalmic)

• 
  Manufacturer: INSPIRE
  
  Approval date: April 27, 2007
  
  Strength(s): 1% ^[RLD]

Has a generic version of Azasite been approved?

No. There is currently no therapeutically equivalent version of Azasite available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Azasite. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Sustained release ophthalmic compositions containing water soluble medicaments
  Patent 6,159,458
  Issued: December 12, 2000
  Inventor(s): Bowman; Lyle M. & Pfeiffer; James F.
  Assignee(s): InSite Vision
  An ophthalmic composition that provides sustained release of a water soluble medicament is formed comprising a crosslinked carboxy-containing polymer, a medicament, a sugar and water. The composition has a pH of at least 6.7 but a viscosity of from about 1000 to 5000 cps.
  
  Patent expiration dates:
  
  
  • November 4, 2017
    
    ✓ 
    Patent use: METHOD OF COMBATING BACTERIA IN A PATIENT
    ✓ 
    Drug product
  
  



• 
  Topical treatment or prevention of ocular infections
  Patent 6,239,113
  Issued: May 29, 2001
  Inventor(s): Dawson; Chandler R. & Bowman; Lyle M.
  Assignee(s): InSite Vision, Incorporated
  The topical application of an azalide antibiotic such as azithromycin to the eye is useful in treating or preventing ocular infections. In one embodiment, the azalide antibiotic is supplied to the eye in a depot for sustained release. A more convenient dosing regimen can also be provided by the use of an appropriate depot. Furthermore, a composition containing a combination of medicaments is also provided.
  
  Patent expiration dates:
  
  
  • March 31, 2019
    
    ✓ 
    Patent use: METHOD OF COMBATING BACTERIA IN A PATIENT
  
  



• 
  Topical treatment or prevention of ocular infections
  Patent 6,569,443
  Issued: May 27, 2003
  Inventor(s): Chandler R.; Dawson & Lyle M.; Bowman
  Assignee(s): Insite Vision, Inc.
  The topical application of an azalide antibiotic such as azithromycin to the eye is useful in treating or preventing ocular infections. In one embodiment, the azalide antibiotic is supplied to the eye in a depot for sustained release. A more convenient dosing regimen can also be provided by the use of an appropriate depot. Furthermore, a composition containing a combination of medicaments is also provided.
  
  Patent expiration dates:
  
  
  • March 31, 2019
    
    ✓ 
    Patent use: METHOD OF COMBATING BACTERIA IN A PATIENT
    ✓ 
    Drug product
  
  



• 
  Method of treating eye infections with azithromycin
  Patent 6,861,411
  Issued: March 1, 2005
  Inventor(s): Ahmed; Imran
  Assignee(s): Pfizer, Inc.
  The invention features methods and compositions for treating ocular infections. The method comprises topically administering to an eye of an animal in need of such treatment an ocular infection-treating amount of azithromycin.
  
  Patent expiration dates:
  
  
  • November 25, 2018
    
    ✓ 
    Patent use: METHOD OF COMBATING BACTERIA IN A PATIENT
  
  



• 
  Topical treatment for prevention of ocular infections
  Patent 7,056,893
  Issued: June 6, 2006
  Inventor(s): Roy; Samir & Bowman; Lyle M.
  Assignee(s): Insite Vision, Inc.
  Azalide antibiotics such as azithromycin are useful in the treatment and prevention of infections by bacteria and other parasites. Stabilized aqueous compositions containing azithromycin suitable for administration without reconstitution are provided for. Also provided for are aqueous formulations suitable for ocular administration in a employing a convenient dosing formulation suitable for administration in depot formats.
  
  Patent expiration dates:
  
  
  • March 31, 2019
    
    ✓ 
    Patent use: METHOD OF COMBATING BACTERIA IN A PATIENT
    ✓ 
    Drug product
  
  

See also...

• AzaSite Consumer Information (Drugs.com)
• Azasite Drops Consumer Information (Wolters Kluwer)
• AzaSite Consumer Information (Cerner Multum)
• AzaSite Advanced Consumer Information (Micromedex)
• Azithromycin Drops Consumer Information (Wolters Kluwer)
• Azithromycin ophthalmic Consumer Information (Cerner Multum)
• Azithromycin Ophthalmic Advanced Consumer Information (Micromedex)